UA94931C2 - Способ получения (s)- n-метил-3-(нафтилокси)-3-(2-тиенил)пропиламингидрохлорида (дулоксетина) - Google Patents
Способ получения (s)- n-метил-3-(нафтилокси)-3-(2-тиенил)пропиламингидрохлорида (дулоксетина)Info
- Publication number
- UA94931C2 UA94931C2 UAA200810089A UAA200810089A UA94931C2 UA 94931 C2 UA94931 C2 UA 94931C2 UA A200810089 A UAA200810089 A UA A200810089A UA A200810089 A UAA200810089 A UA A200810089A UA 94931 C2 UA94931 C2 UA 94931C2
- Authority
- UA
- Ukraine
- Prior art keywords
- formula
- naphthyloxy
- thienyl
- propylamine
- dimethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Способ получения (S)-N-метил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина формулы I и его фармацевтически приемлемых солей, который включает: а) взаимодействие (RS)-N,N-диметил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина формулы III с оптически активной D-винной кислотой или кислой солью, полученной из D-винной кислоты, с образованием смеси диастереоизомерных солей N,N-диметил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина и D-винной кислоты (2:1), b) выделение соли (S)-N,N-диметил-3-(нафтилокси)-3-(2-тиенил)пропиламин/ D-тартрата (2:1) из смеси диастереоизомерных солей в органическом растворителе, воде или их смеси, и выделение (S)-N,N-диметил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина формулы (S)-(III) путем воздействия неорганической или органической основы, с) деметилирование (S)-N,N-диметил-3-(1-нафтилокси)-3-(2-тиенил)пропиламина путем воздействия алкилхлорформиата формулы ClCOOR (R=C1-C5-алкил, или С6-С12-арил или алкиларил), в частности фенил-, этил- или метилхлороформата, и d) гидролитическое выделение основы дулоксетина формулы I и необязательное преобразование основы в соль пригодной кислотой или в соль слабой основы, в котором, как оптически активное вещество, на стадии (а) используют D-винную кислоту в молярном соотношении 1:2 в отношении вещества формулы III или кислый D-тартрат щелочного металла, или тартрат аммония, или, альтеративно, тартрат алкиламония формулы IV в молярном соотношении 1:1 в отношении вещества формулы III.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20060007A CZ299270B6 (cs) | 2006-01-04 | 2006-01-04 | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
Publications (1)
Publication Number | Publication Date |
---|---|
UA94931C2 true UA94931C2 (ru) | 2011-06-25 |
Family
ID=38042666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200810089A UA94931C2 (ru) | 2006-01-04 | 2006-12-22 | Способ получения (s)- n-метил-3-(нафтилокси)-3-(2-тиенил)пропиламингидрохлорида (дулоксетина) |
Country Status (9)
Country | Link |
---|---|
US (2) | US8071791B2 (ru) |
EP (2) | EP1968965B1 (ru) |
AT (1) | ATE523503T1 (ru) |
CZ (1) | CZ299270B6 (ru) |
EA (1) | EA014559B1 (ru) |
PL (1) | PL1968965T3 (ru) |
PT (1) | PT1968965E (ru) |
UA (1) | UA94931C2 (ru) |
WO (1) | WO2007076733A2 (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090221668A1 (en) * | 2005-12-12 | 2009-09-03 | Medichem, S.A. | Synthesis and preparations of duloxetine salts |
US8278463B2 (en) | 2008-04-04 | 2012-10-02 | Ranbaxy Laboratories Limited | Process for the preparation of pure duloxetine hydrochloride |
US10227825B2 (en) * | 2011-08-05 | 2019-03-12 | Coiled Tubing Specialties, Llc | Steerable hydraulic jetting nozzle, and guidance system for downhole boring device |
US20180357365A1 (en) * | 2015-10-02 | 2018-12-13 | Phylagen, Inc. | Product authentication and tracking |
CN114163415B (zh) * | 2021-12-01 | 2023-03-03 | 珠海润都制药股份有限公司 | 一种盐酸度洛西汀中间体的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880007433A (ko) | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
DE10212301A1 (de) | 2002-03-20 | 2003-10-02 | Bayer Ag | Verfahren zur Herstellung von Aryl-aminopropanolen |
ATE444949T1 (de) | 2002-07-09 | 2009-10-15 | Lonza Ag | Verfahren zur herstellung von n-monoalkyl-beta- aminoalkoholen |
GB0229583D0 (en) * | 2002-12-19 | 2003-01-22 | Cipla Ltd | A process for preparing duloxetine and intermediates for use therein |
GB0410470D0 (en) | 2004-05-11 | 2004-06-16 | Cipla Ltd | Pharmaceutical compound and polymorphs thereof |
CZ297555B6 (cs) * | 2004-10-26 | 2007-02-07 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu) |
CZ297560B6 (cs) | 2004-10-26 | 2007-02-07 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu) |
WO2006099433A1 (en) * | 2005-03-14 | 2006-09-21 | Teva Pharmaceutical Industries Ltd. | Pure duloxetine hydrochloride |
WO2006126213A1 (en) | 2005-05-24 | 2006-11-30 | Matrix Laboratories Ltd | An improved process for the preparation of duloxetine |
-
2006
- 2006-01-04 CZ CZ20060007A patent/CZ299270B6/cs not_active IP Right Cessation
- 2006-12-22 EA EA200801635A patent/EA014559B1/ru not_active IP Right Cessation
- 2006-12-22 AT AT06840860T patent/ATE523503T1/de not_active IP Right Cessation
- 2006-12-22 EP EP06840860A patent/EP1968965B1/en not_active Not-in-force
- 2006-12-22 PT PT06840860T patent/PT1968965E/pt unknown
- 2006-12-22 US US12/159,905 patent/US8071791B2/en not_active Expired - Fee Related
- 2006-12-22 EP EP10000373.0A patent/EP2172464B1/en not_active Not-in-force
- 2006-12-22 WO PCT/CZ2006/000096 patent/WO2007076733A2/en active Application Filing
- 2006-12-22 PL PL06840860T patent/PL1968965T3/pl unknown
- 2006-12-22 UA UAA200810089A patent/UA94931C2/ru unknown
-
2011
- 2011-10-05 US US13/253,441 patent/US8207356B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2172464A2 (en) | 2010-04-07 |
US20120029212A1 (en) | 2012-02-02 |
EA200801635A1 (ru) | 2008-10-30 |
PT1968965E (pt) | 2011-11-10 |
US20080293952A1 (en) | 2008-11-27 |
CZ299270B6 (cs) | 2008-06-04 |
EP2172464A3 (en) | 2010-05-12 |
WO2007076733A3 (en) | 2007-08-23 |
PL1968965T3 (pl) | 2011-12-30 |
EP2172464B1 (en) | 2015-08-26 |
US8207356B2 (en) | 2012-06-26 |
WO2007076733A2 (en) | 2007-07-12 |
US8071791B2 (en) | 2011-12-06 |
ATE523503T1 (de) | 2011-09-15 |
EA014559B1 (ru) | 2010-12-30 |
CZ20067A3 (cs) | 2007-07-11 |
EP1968965B1 (en) | 2011-09-07 |
EP1968965A2 (en) | 2008-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1758879T3 (pl) | Sposób wytwarzania chlorowodorku (S)-N-metylo-3-(1-naftyloksy)-3-(2-tienylo)propyloaminy (Duloksetyny) | |
UA94931C2 (ru) | Способ получения (s)- n-метил-3-(нафтилокси)-3-(2-тиенил)пропиламингидрохлорида (дулоксетина) | |
IL184189A0 (en) | Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine | |
BRPI0500585A (pt) | Processo para a sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável | |
BRPI0500480B8 (pt) | processo para a síntese de ivabradina bem como processos para a resolução de amina e para a síntese de composto relacionado com a síntese de ivabradina | |
GEP20125566B (en) | Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
MX2007006081A (es) | Tetrahidroisoquinolinas 4-fenil-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina. | |
WO2006027798A3 (en) | A process for preparation of an antidepressant compound | |
AR049443A1 (es) | Derivados de pirrolpiridinas | |
NZ592543A (en) | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | |
MX2007006082A (es) | Tetrahidroisoquinolinas aril- y heteroaril-sustituidas, y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina. | |
AR058321A1 (es) | Sintesis mejorada y preparaciones de sales de duloxetina | |
PE20030116A1 (es) | Propanaminas heteroariloxi 3-sustituidas como inhibidores de la recaptacion de serotonina y norepinefrina | |
WO2007020527A3 (en) | Process for the preparation of strontium ranelate | |
DE602005026785D1 (de) | Verwendung von sphingolipiden bei der behandlung und vorbeugung von typ-2-diabetes mellitus, insulinresistenz und metabolismussyndrom | |
ATE396189T1 (de) | Cyanopyrrolhaltige cyclische carbamat- und thiocarbamatbiaryle und verfahren zu deren herstellung | |
MA32579B1 (fr) | Derives de carbamates d'alkylthiazoles, leur preparation et leur utilisation comme inhbiteurs de l'enzyme faah | |
MA32193B1 (fr) | Procede de preparation de combretastatine | |
CA2513542A1 (en) | 3-methylamino-1-(2-thienyl)-1-propanone, production and use thereof | |
UA98631C2 (ru) | Способ очистки (s)-n-метил-3-(1-нафтилокси)-3-( 2-тиенил)пропиламина гидрохлорида (дулоксетина) | |
ZA201201570B (en) | A method of crystallization of (s)-n-methyl-3-1(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) | |
WO2011033366A3 (en) | Process for the preparation of duloxetine hydrochloride and its precursors | |
MA32527B1 (fr) | Derives 6-heterocyclique -imidazo[1,2-a]pyrroine-2-carboxamides, leur preparation et leur application en therapeutique | |
WO2008107911A3 (en) | Novel process for preparation of duloxetine hydrochloride | |
WO2008093360A3 (en) | A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride |